logo

Summit Therapeutics Inc (SMMT) Stock: From Low to High in 52 Weeks

Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Summit Therapeutics Inc’s current trading price is -31.96% away from its 52-week high, while its distance from the 52-week low is 998.10%. The stock’s price range over this period has fluctuated between $2.10 and $33.89. The company, operating within the financial sector, had a trading volume of approximately 3.31 million for the day, which was noticeably higher than the average daily share volume of 2.17 million over the last 3 months.

The market performance of Summit Therapeutics Inc’s stock has been harmonious in recent times. Over the last year, the company’s stock reached its highest point at $33.89 on 09/16/24, while the lowest value for the same duration was $2.10 on 05/28/24.

Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis

Summit Therapeutics Inc (SMMT) has experienced a quarterly rise of 25.94% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 17.00B and boasts a workforce of 105 employees.

Analyzing Trading Volume and Moving Average Trends

Based on Barchart.com data, the company’s moving average over the 100-day period was 19.82, with a change in price of +0.42. Similarly, Summit Therapeutics Inc recorded 2,393,286 in trading volume during the last 100 days, posting a change of +1.86%.

Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis

The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for SMMT stands at 0.07. Similarly, the long-term debt-to-equity ratio is also 0.01.

SMMT Stock Stochastic Average

Today’s raw stochastic average for Summit Therapeutics Inc over the last 50 days is 77.28%.This indicates a increase from the raw stochastic average of the past 20 days, which was 70.52%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 53.09% and 47.24%, respectively.

SMMT Stock Price Performance Analysis

Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. Until today this year the stock’s price performance recorded an increase of 29.22%. However, over the last six months, the performance has been weaker by 88.24%. The price of SMMT increased 4.34% over the last 30 days. And in the last five days, it has surged by 17.83%.

Most Popular